ARQT

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT · CIK 1787306 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$376M
20202025
Net Income−$16M
20202025
Operating CF−$6M
20202025
Free Cash Flow−$6M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.4B$0.2B————
Cost of Revenue$0.0B$0.0B$0.0B———
Gross Profit——————
R&D Expense$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B
SG&A Expense$0.3B$0.2B$0.2B———
Operating Income$-0.0B$-0.1B$-0.2B$-0.3B$-0.2B$-0.1B
Net Income$-0.0B$-0.1B$-0.3B$-0.3B$-0.2B$-0.0B
EPS (Basic)$-0.13$-1.16$-3.78$-5.66$-4.18—
EPS (Diluted)$-0.13$-1.16$-3.78$-5.66$-4.18—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.4B$0.3B$0.3B$0.4B$0.4B$0.3B
Current Assets$0.4B$0.3B$0.3B$0.4B$0.4B$0.3B
Cash & Equivalents$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B
Total Liabilities$0.2B$0.2B$0.3B$0.2B$0.1B$0.0B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.2B$0.2B$0.1B$0.2B$0.3B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.0B$-0.1B$-0.2B$-0.3B$-0.2B$-0.1B
Investing Cash Flow$-0.0B$0.0B$0.2B$-0.1B$-0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.1B$0.1B$0.3B$0.3B$0.3B
← Companies